Shengtai Pharmaceutical, Inc. (SGTI) Cash Flow Statement

Net income	562.74K
Depreciation	7.27M
Amortization	62.93K
Bad debt (reduction) provision
Share based compensation to employees
Earnings on equity investment
Change in operating assets and liabilities:
Accounts receivable	-1.28M
Notes receivable	-4.14M
Other receivables	5.29M
Inventories	-13.29M
Prepayments and other assets	-2.07M
Other payable	-383.81K
Customer deposit	2.97M
Taxes payable	68.97K
Net cash (used in) provided by operating activities	-4.4M
Increase in equity investment	-318.81K
Purchase plant and equipment	-4.28K
Additions to construction in progress
Advances for construction
Increase in land use right	-70.62K
Net cash used in investing activities	936.77K
Decrease in restricted cash	8.26M
Borrowings on notes payable - banks	13.53M
Principal payments on notes payable - banks	-23.63M
Borrowings on short term loans
Principal payments on short term loans	-72.63M
Borrowings on employee loans
Borrowings on long term loans
Net cash provided by (used in) financing activities	5.68M
EFFECTS OF EXCHANGE RATE CHANGE IN CASH	581.31K
DECREASE IN CASH & CASH EQUIVALENTS	2.8M
CASH & CASH EQUIVALENTS, beginning of year	4.9M
CASH & CASH EQUIVALENTS, end of year	7.71M
Interest Paid	3.76M
Income taxes	3.8K
Decrease of other receivable for acquisition of plant and equipment
Transfers of construction in progress-related inventory to plant and equipment
Acquisition of plant and equipment on credit (accounts payable)	6.83M
Completion of construction-in-progress (transferred to plant and equipment)	7.24M
Change in operating assets and liabilities:
Accounts payable and accrued liabilities
Change in operating assets and liabilities:
Accounts payable and accrued liabilities

Entities mentioned with SGTI

Notable Mergers and Acquisitions | View Related Stories »
Show More...

View All Entities

This is a StreetInsider.com Premium Only Page

More on SGTI

Financials

News

SGTI Cash Flow Statement

Entities mentioned with SGTI

Free News Feed